| Followers | 200 |
| Posts | 25597 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Tuesday, January 09, 2024 11:05:04 PM
I don’t think she could stop him and he took far more damage with NWBO than any company he has ever attacked, which I think is why he is so determined here. Not because some CEO confronted him. He is not dissuaded so easily. More likely something happened behind the scenes and he made some mistake.
In this case he had to leave The Street, and the Washington Post absolutely savaged him while CREW, the DC public interest organization, threatened and tried to report him to the SEC. He was absolutely embarrassed and furious. So I think he got more than he could handle here and is one of those a/holes that simply feels if he could cause them to fail, regardless of the merits of DCVax-L, which he would never, ever admit, no matter what, then he would be proven right by the economic failure.
I think he will always be a pain in the neck, but I also think he losses the longer he persists, once this succeeds. So we will see what he does. He doesn’t seem to be too bright.
In this case he had to leave The Street, and the Washington Post absolutely savaged him while CREW, the DC public interest organization, threatened and tried to report him to the SEC. He was absolutely embarrassed and furious. So I think he got more than he could handle here and is one of those a/holes that simply feels if he could cause them to fail, regardless of the merits of DCVax-L, which he would never, ever admit, no matter what, then he would be proven right by the economic failure.
I think he will always be a pain in the neck, but I also think he losses the longer he persists, once this succeeds. So we will see what he does. He doesn’t seem to be too bright.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
